Clinical Research

Clinical Research Experts

Dr Roger Louis

Global Chief Compliance Officer
Novelion Therapeutics


  Mr. Louis received his J.D. from University of Chicago School of Law and his B.A. from Tufts University.

Research Interest

Roger Louis served as Aegerion Pharmceuticals' Senior Vice President, Global Chief Compliance Officer since November 2015. Mr. Louis has extensive experience in compliance and risk management, having served most recently as Senior Vice President, Compliance & Risk Management, Chief Compliance Officer at Cubist Pharmaceuticals prior to its acquisition by Merck. Mr. Louis joined Cubist from Biogen Idec where he was Senior Vice President, Chief Compliance Officer. From 1997 to 2012, he held positions of increasing responsibility at Genzyme Corporation, including Senior Vice President, Chief Compliance Officer. Mr. Louis began his legal career as an Associate at Hale & Dorr in Boston where he practiced corporate and securities law.

Global Experts from Macedonia

Global Experts in Subject

Share This Profile
Recommended Conferences